aminotris(methylenephosphonato)diamminoplatinum (ii) has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altmann, A; Haberkorn, U; Kaick, GV; Klenner, T; Oberdorfer, F; Stöhr, M; Strauss, LG; Wallich, R | 1 |
| Keppler, BK; Klenner, T; Krempien, B; Schmähl, D; Wingen, F | 1 |
2 other study(ies) available for aminotris(methylenephosphonato)diamminoplatinum (ii) and Bone Cancer
| Article | Year |
|---|---|
Metabolic and transcriptional changes in osteosarcoma cells treated with chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Deoxyglucose; Flow Cytometry; Fluorodeoxyglucose F18; Lung Neoplasms; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Rats; Thymidine; Transcription, Genetic | 1994 |
Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?
Topics: Animals; Bone and Bones; Bone Neoplasms; Carcinoma 256, Walker; Diphosphonates; Drug Evaluation, Preclinical; Organophosphorus Compounds; Organoplatinum Compounds; Osteosarcoma; Pamidronate; Rats | 1990 |